Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 122

1.

Endoscopic endonasal cyst fenestration into the sphenoid sinus using the mucosa coupling method for symptomatic Rathke's cleft cyst: a novel method for maintaining cyst drainage to prevent recurrence.

Kino H, Akutsu H, Tanaka S, Hara T, Miyamoto H, Sakamoto N, Takano S, Masumoto T, Shiigai M, Ishikawa E, Matsumura A.

J Neurosurg. 2019 Nov 1:1-11. doi: 10.3171/2019.8.JNS191103. [Epub ahead of print]

PMID:
31675725
2.

Pure germinoma occurring 11 years after total pineal mature teratoma removal: a case report and review of the literature.

Sakakura K, Muroi A, Tsurubuchi T, Takano S, Ishikawa E, Matsumura A.

Childs Nerv Syst. 2019 Dec;35(12):2423-2426. doi: 10.1007/s00381-019-04332-8. Epub 2019 Aug 5.

PMID:
31385089
3.

Genetic evidence implies that primary and relapsed tumors arise from common precursor cells in primary central nervous system lymphoma.

Hattori K, Sakata-Yanagimoto M, Kusakabe M, Nanmoku T, Suehara Y, Matsuoka R, Noguchi M, Yokoyama Y, Kato T, Kurita N, Nishikii H, Obara N, Takano S, Ishikawa E, Matsumura A, Muratani M, Hasegawa Y, Chiba S.

Cancer Sci. 2019 Jan;110(1):401-407. doi: 10.1111/cas.13848. Epub 2018 Nov 18.

4.

Random Skin Biopsies Before Brain Biopsy for Intravascular Large B-Cell Lymphoma.

Yamada E, Ishikawa E, Watanabe R, Matsumura H, Sakamoto N, Ishii A, Tamaoka A, Hattori K, Obara N, Chiba S, Nakamagoe K, Matsuda M, Tsurubuchi T, Tomidokoro Y, Akutsu H, Zaboronok A, Shibuya M, Takano S, Matsumura A.

World Neurosurg. 2019 Jan;121:e364-e369. doi: 10.1016/j.wneu.2018.09.110. Epub 2018 Sep 25.

PMID:
30261371
5.

Evaluation of the extent of resection and detection of ischemic lesions with intraoperative MRI in glioma surgery: is intraoperative MRI superior to early postoperative MRI?

Masuda Y, Akutsu H, Ishikawa E, Matsuda M, Masumoto T, Hiyama T, Yamamoto T, Kohzuki H, Takano S, Matsumura A.

J Neurosurg. 2018 Aug 1:1-8. doi: 10.3171/2018.3.JNS172516. [Epub ahead of print]

PMID:
30095340
6.

Clinical and biological significance of adamantinomatous craniopharyngioma with CTNNB1 mutation.

Hara T, Akutsu H, Takano S, Kino H, Ishikawa E, Tanaka S, Miyamoto H, Sakamoto N, Hattori K, Sakata-Yanagimoto M, Chiba S, Hiyama T, Masumoto T, Matsumura A.

J Neurosurg. 2018 Jul 1:1-10. doi: 10.3171/2018.3.JNS172528. [Epub ahead of print]

PMID:
30074466
7.

BAI1 Suppresses Medulloblastoma Formation by Protecting p53 from Mdm2-Mediated Degradation.

Zhu D, Osuka S, Zhang Z, Reichert ZR, Yang L, Kanemura Y, Jiang Y, You S, Zhang H, Devi NS, Bhattacharya D, Takano S, Gillespie GY, Macdonald T, Tan C, Nishikawa R, Nelson WG, Olson JJ, Van Meir EG.

Cancer Cell. 2018 Jun 11;33(6):1004-1016.e5. doi: 10.1016/j.ccell.2018.05.006.

8.

Symptomatic Remote Cyst after BCNU Wafer Implantation for Malignant Glioma.

Matsumura H, Ishikawa E, Matsuda M, Sakamoto N, Akutsu H, Takano S, Matsumura A.

Neurol Med Chir (Tokyo). 2018 Jun 15;58(6):270-276. doi: 10.2176/nmc.cr.2017-0218. Epub 2018 May 21.

9.

Anatomical variations of the torcular Herophili: macroscopic study and clinical aspects.

Matsuda W, Sonomura T, Honma S, Ohno S, Goto T, Hirai S, Itoh M, Honda Y, Fujieda H, Udagawa J, Takano S, Fujiyama F, Ueda S.

Anat Sci Int. 2018 Sep;93(4):464-468. doi: 10.1007/s12565-018-0436-z. Epub 2018 Mar 12.

PMID:
29532422
10.

Prognostic analysis of patients who underwent gross total resection of newly diagnosed glioblastoma.

Matsuda M, Kohzuki H, Ishikawa E, Yamamoto T, Akutsu H, Takano S, Mizumoto M, Tsuboi K, Matsumura A.

J Clin Neurosci. 2018 Apr;50:172-176. doi: 10.1016/j.jocn.2018.01.009. Epub 2018 Feb 1.

PMID:
29396060
11.

MyD88 Mutation in Elderly Predicts Poor Prognosis in Primary Central Nervous System Lymphoma: Multi-Institutional Analysis.

Takano S, Hattori K, Ishikawa E, Narita Y, Iwadate Y, Yamaguchi F, Nagane M, Akimoto J, Oka H, Tanaka S, Sakata M, Matsuda M, Yamamoto T, Chiba S, Matsumura A.

World Neurosurg. 2018 Apr;112:e69-e73. doi: 10.1016/j.wneu.2017.12.028. Epub 2017 Dec 16.

PMID:
29258950
12.

Clinical significance of disease-specific MYD88 mutations in circulating DNA in primary central nervous system lymphoma.

Hattori K, Sakata-Yanagimoto M, Suehara Y, Yokoyama Y, Kato T, Kurita N, Nishikii H, Obara N, Takano S, Ishikawa E, Matsumura A, Hasegawa Y, Chiba S.

Cancer Sci. 2018 Jan;109(1):225-230. doi: 10.1111/cas.13450. Epub 2017 Dec 23.

13.

Combined Endoscopic Endonasal and Transoral Surgery for a Chordoma in the Whole Clivus With Marked Caudal Extension.

Hara T, Akutsu H, Yamamoto T, Tanaka S, Yasuda M, Takano S, Kino H, Miyamoto H, Matsumura A.

Oper Neurosurg (Hagerstown). 2018 Apr 1;14(4):463-464. doi: 10.1093/ons/opx168. No abstract available.

PMID:
28961728
14.

A single institutional retrospective evaluation for younger patients with primary central nervous lymphomas on a modified R-MPV regimen followed by radiotherapy and high dose cytarabine.

Hattori K, Sakata-Yanagimoto M, Okoshi Y, Kato T, Kurita N, Yokoyama Y, Obara N, Takano S, Ishikawa E, Yamamoto T, Matsumura A, Hasegawa Y, Chiba S.

J Clin Exp Hematop. 2017 Oct 12;57(2):41-46. doi: 10.3960/jslrt.17012. Epub 2017 Aug 4.

15.

[Combination Therapy with Radiation, Temozolomide, and Bevacizumab after Partial Tumor Removal in Glioblastoma Patients with Low Performance Status].

Nakao J, Ishikawa E, Matsuda M, Yamamoto T, Takano S, Matsumura A.

Gan To Kagaku Ryoho. 2017 Jun;44(6):495-500. Japanese.

PMID:
28698441
16.

Intradiploic Arachnoid Cyst with Meningothelial Hyperplasia: A Case Report.

Saida H, Ishikawa E, Sakamoto N, Hara T, Terakado T, Masumoto T, Akutsu H, Shibuya M, Yamamoto T, Takano S, Matsumura A.

NMC Case Rep J. 2016 Dec 5;4(1):19-22. doi: 10.2176/nmccrj.cr.2016-0147. eCollection 2017 Jan.

17.

Assessment of PD-1 positive cells on initial and secondary resected tumor specimens of newly diagnosed glioblastoma and its implications on patient outcome.

Miyazaki T, Ishikawa E, Matsuda M, Akutsu H, Osuka S, Sakamoto N, Takano S, Yamamoto T, Tsuboi K, Matsumura A.

J Neurooncol. 2017 Jun;133(2):277-285. doi: 10.1007/s11060-017-2451-7. Epub 2017 Apr 26.

PMID:
28447277
18.

Efficacy of bevacizumab therapy in recurrent malignant gliomas in relation to the prior recurrence pattern or tumor location.

Matsuda M, Ishikawa E, Yamamoto T, Akutsu H, Takano S, Matsumura A.

J Clin Neurosci. 2017 Jun;40:115-119. doi: 10.1016/j.jocn.2017.02.025. Epub 2017 Feb 27.

PMID:
28246006
19.

The anti-angiogenic role of soluble-form VEGF receptor in malignant gliomas.

Takano S, Ishikawa E, Matsuda M, Sakamoto N, Akutsu H, Yamamoto T, Matsumura A.

Int J Oncol. 2017 Feb;50(2):515-524. doi: 10.3892/ijo.2016.3810. Epub 2016 Dec 19.

PMID:
28000842
20.

High-speed Videolaryngoscopy: Quantitative Parameters of Glottal Area Waveforms and High-speed Kymography in Healthy Individuals.

Tsutsumi M, Isotani S, Pimenta RA, Dajer ME, Hachiya A, Tsuji DH, Tayama N, Yokonishi H, Imagawa H, Yamauchi A, Takano S, Sakakibara KI, Montagnoli AN.

J Voice. 2017 May;31(3):282-290. doi: 10.1016/j.jvoice.2016.09.026. Epub 2016 Oct 25.

PMID:
27793519
21.

Proton beam therapy with concurrent chemotherapy for glioblastoma multiforme: comparison of nimustine hydrochloride and temozolomide.

Mizumoto M, Yamamoto T, Ishikawa E, Matsuda M, Takano S, Ishikawa H, Okumura T, Sakurai H, Matsumura A, Tsuboi K.

J Neurooncol. 2016 Oct;130(1):165-170. Epub 2016 Aug 17.

PMID:
27535747
22.
23.

Long-term results of cabergoline therapy for macroprolactinomas and analyses of factors associated with remission after withdrawal.

Watanabe S, Akutsu H, Takano S, Yamamoto T, Ishikawa E, Suzuki H, Matsumura A.

Clin Endocrinol (Oxf). 2017 Feb;86(2):207-213. doi: 10.1111/cen.13240. Epub 2016 Oct 11.

PMID:
27651307
24.

[5-Aminolevulinic acid fluorescence-guided surgery for brain tumors].

Eiichi Ishikawa, Matsuda M, Yamamoto T, Takano S, Matsumura A.

Nihon Rinsho. 2016 Sep;74 Suppl 7:545-552. Japanese. No abstract available.

PMID:
30634811
25.

[Anaplastic astrocytoma].

Takano S.

Nihon Rinsho. 2016 Sep;74 Suppl 7:377-386. Japanese. No abstract available.

PMID:
30634781
26.

[Bevacizumab Treatment for Malignant Glioma Based on Basic Research and Clinical Trial].

Takano S.

Gan To Kagaku Ryoho. 2016 Jun;43(6):694-701. Japanese. No abstract available.

PMID:
27459747
27.

MYD88 (L265P) mutation is associated with an unfavourable outcome of primary central nervous system lymphoma.

Hattori K, Sakata-Yanagimoto M, Okoshi Y, Goshima Y, Yanagimoto S, Nakamoto-Matsubara R, Sato T, Noguchi M, Takano S, Ishikawa E, Yamamoto T, Matsumura A, Chiba S.

Br J Haematol. 2017 May;177(3):492-494. doi: 10.1111/bjh.14080. Epub 2016 May 10. No abstract available.

PMID:
27161435
28.

Hyperfractionated high-dose proton beam radiotherapy for clival chordomas after surgical removal.

Hayashi Y, Mizumoto M, Akutsu H, Takano S, Matsumura A, Okumura T, Kawabe T, Zenkoh J, Sakurai H, Tsuboi K.

Br J Radiol. 2016 Jul;89(1063):20151051. doi: 10.1259/bjr.20151051. Epub 2016 Apr 21.

29.

Immunohistochemistry on IDH 1/2, ATRX, p53 and Ki-67 substitute molecular genetic testing and predict patient prognosis in grade III adult diffuse gliomas.

Takano S, Ishikawa E, Sakamoto N, Matsuda M, Akutsu H, Noguchi M, Kato Y, Yamamoto T, Matsumura A.

Brain Tumor Pathol. 2016 Apr;33(2):107-16. doi: 10.1007/s10014-016-0260-x. Epub 2016 Mar 11.

PMID:
26968173
30.

[Endoscopic Endonasal Transethmoidal Biopsy for IgG4-Related Intraorbital Pseudotumor:A Case Report].

Takahashi T, Akutsu H, Yamamoto T, Tanaka S, Ishikawa E, Matsuda M, Masuda Y, Takano S, Matsumura A.

No Shinkei Geka. 2016 Jan;44(1):47-52. doi: 10.11477/mf.1436203206. Japanese.

PMID:
26771096
31.

Early Postoperative Expansion of Parenchymal High-intensity Areas on T2-weighted Imaging Predicts Delayed Cerebral Edema Caused by Carmustine Wafer Implantation in Patients with High-grade Glioma.

Masuda Y, Ishikawa E, Yamamoto T, Matsuda M, Akutsu H, Kohzuki H, Nakai K, Okamoto E, Takano S, Masumoto T, Matsumura A.

Magn Reson Med Sci. 2016 Jul 11;15(3):299-307. doi: 10.2463/mrms.mp.2015-0054. Epub 2015 Dec 28.

32.

An Alkyloxyphenyl Group as a Sterically Hindered Substituent on a Triphenylamine Donor Dye for Effective Recombination Inhibition in Dye-Sensitized Solar Cells.

Murakami TN, Koumura N, Yoshida E, Funaki T, Takano S, Kimura M, Mori S.

Langmuir. 2016 Feb 2;32(4):1178-83. doi: 10.1021/acs.langmuir.5b04127. Epub 2016 Jan 15.

PMID:
26672394
33.

Intraparenchymal brain lesion biopsy guided by a rigid endoscope and navigation system.

Ishikawa E, Yamamoto T, Matsuda M, Akutsu H, Zaboronok A, Kohzuki H, Miki S, Takano S, Matsumura A.

Surg Neurol Int. 2015 Sep 18;6:149. doi: 10.4103/2152-7806.165764. eCollection 2015.

34.

Sodium Bicarbonate Facilitates Hemostasis in the Presence of Cerebrospinal Fluid Through Amplification of Platelet Aggregation.

Kozuma Y, Yamamoto T, Ishikawa E, Yoshida F, Akutsu H, Matsuda M, Nakai K, Tsuruta W, Takano S, Matsumura A, Ninomiya H.

Neurosurgery. 2016 Feb;78(2):274-84. doi: 10.1227/NEU.0000000000001058.

PMID:
26457486
35.

A high-sensitive HMab-2 specifically detects IDH1-R132H, the most common IDH mutation in gliomas.

Fujii Y, Ogasawara S, Oki H, Liu X, Kaneko MK, Takano S, Kato Y.

Biochem Biophys Res Commun. 2015 Oct 30;466(4):733-9. doi: 10.1016/j.bbrc.2015.09.070. Epub 2015 Sep 14.

PMID:
26381180
36.

Cranial Base Repair Using Suturing Technique Combined with a Mucosal Flap for Cerebrospinal Fluid Leakage During Endoscopic Endonasal Surgery.

Hara T, Akutsu H, Yamamoto T, Tanaka S, Takano S, Ishikawa E, Matsuda M, Matsumura A.

World Neurosurg. 2015 Dec;84(6):1887-93. doi: 10.1016/j.wneu.2015.08.025. Epub 2015 Sep 1.

PMID:
26341445
37.

Improvement of Long-term Results with Neoadjuvant Chemotherapy and Radiotherapy for Central Nervous System Germinoma.

Takano S, Yamamoto T, Ishikawa E, Akutsu H, Nakai K, Matsuda M, Muroi A, Shibata Y, Mizumoto M, Tsuboi K, Matsumura A.

World Neurosurg. 2015 Sep;84(3):846-54. doi: 10.1016/j.wneu.2015.06.029. Epub 2015 Jun 23.

PMID:
26115804
38.

Neuroendoscopy Followed by Radiotherapy in Cystic Craniopharyngiomas--a Long-Term Follow-Up.

Takano S, Akutsu H, Mizumoto M, Yamamoto T, Tsuboi K, Matsumura A.

World Neurosurg. 2015 Nov;84(5):1305-15.e1-2. doi: 10.1016/j.wneu.2015.06.022. Epub 2015 Jun 20.

PMID:
26100163
39.

An Aerodynamic Study of Phonations in Patients With Parkinson Disease (PD).

Ikui Y, Nakamura H, Sano D, Hyakusoku H, Kishida H, Kudo Y, Joki H, Koyano S, Yamauchi A, Takano S, Tayama N, Hirose H, Oridate N, Tanaka F.

J Voice. 2015 May;29(3):273-80. doi: 10.1016/j.jvoice.2014.08.012. Epub 2015 Mar 17.

PMID:
25795370
40.

Diagnostic advantage of double immunohistochemistry using two mutation-specific anti-IDH antibodies (HMab-1 and MsMab-1) in gliomas.

Takano S, Kato Y, Yamamoto T, Liu X, Ishikawa E, Kaneko MK, Ogasawara S, Matsuda M, Noguchi M, Matsumura A.

Brain Tumor Pathol. 2015 Jul;32(3):169-75. doi: 10.1007/s10014-015-0214-8. Epub 2015 Feb 5.

PMID:
25652153
41.

Correlations of vascular architecture and angiogenesis with pituitary adenoma histotype.

Takano S, Akutsu H, Hara T, Yamamoto T, Matsumura A.

Int J Endocrinol. 2014;2014:989574. doi: 10.1155/2014/989574. Epub 2014 Nov 9.

42.

Long-term survival after treatment of glioblastoma multiforme with hyperfractionated concomitant boost proton beam therapy.

Mizumoto M, Yamamoto T, Takano S, Ishikawa E, Matsumura A, Ishikawa H, Okumura T, Sakurai H, Miyatake S, Tsuboi K.

Pract Radiat Oncol. 2015 Jan-Feb;5(1):e9-16. doi: 10.1016/j.prro.2014.03.012. Epub 2014 May 19.

PMID:
25413424
43.

Bevacizumab in Japanese patients with malignant glioma: from basic research to clinical trial.

Takano S, Ishikawa E, Nakai K, Matsuda M, Masumoto T, Yamamoto T, Matsumura A.

Onco Targets Ther. 2014 Sep 5;7:1551-62. doi: 10.2147/OTT.S67621. eCollection 2014. Review.

44.

Interferon-β inhibits glioma angiogenesis through downregulation of vascular endothelial growth factor and upregulation of interferon inducible protein 10.

Takano S, Ishikawa E, Matsuda M, Yamamoto T, Matsumura A.

Int J Oncol. 2014 Nov;45(5):1837-46. doi: 10.3892/ijo.2014.2620. Epub 2014 Aug 25.

45.

Malignant lymphoma in the parasellar region.

Koiso T, Akutsu H, Takano S, Yamamoto T, Ishikawa E, Okoshi Y, Matsumura A.

Case Rep Med. 2014;2014:747280. doi: 10.1155/2014/747280. Epub 2014 Feb 10.

46.

Brain metastasis from papillary thyroid carcinomas.

Tsuda K, Tsurushima H, Takano S, Tsuboi K, Matsumura A.

Mol Clin Oncol. 2013 Sep;1(5):817-819. Epub 2013 Jun 26.

47.

Intraoperative pathological diagnosis in 205 glioma patients in the pre-BCNU wafer era: retrospective analysis with intraoperative implantation of BCNU wafers in mind.

Ishikawa E, Yamamoto T, Satomi K, Matsuda M, Akutsu H, Shibuya M, Nakai K, Sakamoto N, Takano S, Matsumura A.

Brain Tumor Pathol. 2014 Jul;31(3):156-61. doi: 10.1007/s10014-014-0177-1. Epub 2014 Feb 18.

PMID:
24535160
48.

CXCL12 secreted from glioma stem cells regulates their proliferation.

Uemae Y, Ishikawa E, Osuka S, Matsuda M, Sakamoto N, Takano S, Nakai K, Yamamoto T, Matsumura A.

J Neurooncol. 2014 Mar;117(1):43-51. doi: 10.1007/s11060-014-1364-y. Epub 2014 Jan 19.

PMID:
24442483
49.

Decrease in the apparent diffusion coefficient in peritumoral edema for the assessment of recurrent glioblastoma treated by bevacizumab.

Takano S, Kimu H, Tsuda K, Osuka S, Nakai K, Yamamoto T, Ishikawa E, Akutsu H, Matsuda M, Matsumura A.

Acta Neurochir Suppl. 2013;118:185-9. doi: 10.1007/978-3-7091-1434-6_34.

PMID:
23564129
50.

Language areas involving the inferior temporal cortex on intraoperative mapping in a bilingual patient with glioblastoma.

Kin H, Ishikawa E, Takano S, Ayuzawa S, Matsushita A, Muragaki Y, Aiyama H, Sakamoto N, Yamamoto T, Matsumura A.

Neurol Med Chir (Tokyo). 2013;53(4):256-8.

Supplemental Content

Loading ...
Support Center